Amarin Corp Plc (AMRN)

[Pharmacydude]

Iryokabu
“Phar­ma­ceu­ti­cal com­pa­nies, which are quickly scal­ing up pro­duc­tion to meet global de­mand, say waiv­ing the in­tel­lec­tual prop­erty on the vac­cines wouldn’t solve sup­ply prob­lems in the short term be­cause con­tract pro­duc­ers lack fa­mil­iar­ity with new tech­nol­ogy be­hind the shots—tech­ni­cal know-how that isn’t shielded by patents.”
Similarly, it wouldn’t solve the supply problem for Vascepa. Not worried, besides it’s not like we have any patents that mean anything anyway.